Floatz logo

AS01 COMPONENT QS-21

Prostate Disorder

Memorial Sloan Kettering Cancer CentermixturePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Prostate Disorder cohort.

Asset / SponsorPhaseRating
DINITROGEN MONOXIDE
Beth Israel Deaconess Medical Center
Phase 4BB
Oxygen
Beth Israel Deaconess Medical Center
Phase 4BB
Epoetin Alfa
Janssen-Ortho Inc., Canada
Phase 3B
Nivolumab
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2B
Olaparib
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2B

View all 26 →

Same molecule, other indications

AS01 COMPONENT QS-21 is also rated in:

cutaneous melanomaDormant
BB
Indicative · Phase 3
66 / 100
View asset →
Alzheimer diseaseDormant
B
Indicative · Phase 2
61 / 100
View asset →
malignant pancreatic neoplasmActive
CCC
Indicative · Phase 2
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →